Brookline Bancorp, Inc. (BRKL) is now among the bigger bargains in its industry.
Within the last year the price ranged from $13.67 – 16.96 and there is a wide opportunity to get in. Its next earnings report will be released on Jan 29, 2020.

Achillion Pharmaceuticals, Inc.(ACHN)

move, based on 2 analysts offering 12 month price targets for Achillion Pharmaceuticals in the last 3 months. The average price target is $6.30 with a high forecast of $6.30 and a low forecast of $6.30. The average price target represents a 2.77% increase from the last price of $6.13.

Analysts like Liisa Bayko from JMP Securities believe that we could see stock price minimum —.

Another prominent analyst, Joseph Schwartz of Leerink Partners rates ACHN as a Hold. The rating was made just 2 months ago.

Achillion Pharmaceuticals, Inc.(ACHN) Recent News Reports

On average 1.0 articles are written each week about ACHN but this week 1 article were written and they were 68% Bullish and 32% Bearish.

Achillion Pharmaceuticals, Inc. Target Levels

The market experts are predicting that ACHN is a Hold. Some other stocks to consider in this sector are:

CATC
HONE
INDB